Subject · Central accountability dossier · SS-2026-030
Official congressional portrait of Brett Guthrie

The signal is in Donor Capture and Family Enrichment.

Guthrie's score is driven by donor capture and family enrichment.

Brett Guthrie

Current memberU.S. House of Representatives

Official assessment

Absolute · Lifetime

46/100

Swamp score
Average plus worst component
Annualized 2.6 pts/yr

Percentile

83Rank 14
of 85*

CleanMedianWorst

*Ranked among the 85 lawmakers scored so far. Full Congress pending.

Last updated 19 Nov 2026 · Methodology v0.4

Subject
Guthrie, Brett
Chamber
U.S. House of Representatives
Party
Republican
State
Kentucky (2nd District)
Tenure
January 2009 – present
Years served
18.0
Status
Active
Committees
Energy and Commerce (Chair; Health Subcommittee Chair 2023–2024)
File no.
SS-2026-030
Method
v0.4 · Quarterly

Component breakdown

Part I8 of 8 scored · Method v0.4
01

Trading

Household + committee jurisdiction

No publicly traded individual stocks and no transaction reports since 2015; holdings are a 401(k), bank accounts, insurance policies, and about twenty exchange-traded and mutual funds, including a technology-sector index fund, whose trades are exempt from transaction reporting as publicly traded excepted investment funds. Near-floor.

4Weight 15% 0255075100
02

Donor Capture

FEC-disclosed patterns

The dominant driver. Career contributions from pharmaceutical and health-products interests exceed $1.8 million, the most of any sitting House Republican; in the 2024 cycle he ranked first in Congress at $507,000, first in the House in health services, and first in Congress in medical devices and drug manufacturing (OpenSecrets data, as reported by Sludge). After he became chairman, PAC receipts for January–September 2025 reached $1.6 million, against $652,000 in the same months of 2023, with first-time gifts from Mercedes-Benz, Sinclair, and Oracle. Political committees supplied about 65 percent of his 2026-cycle contributions through mid-October. He was an original cosponsor of the EPIC Act to delay Medicare negotiation for small-molecule drugs, a bill PhRMA, Pfizer, and Merck frequently listed in lobbying disclosures. Near-total alignment between donors and the committee he chairs, with a documented legislative act in the donors' direction.

Sources: readsludge.com · kentuckylantern.com · fec.gov +1 more

66Weight 15% 0255075100
03

Family Enrichment

Household + documented extended family

Guthrie reports that he owns 25 percent of Trace Die Cast and lists three holdings in it: an irrevocable family trust ($5–25 million, dividends $100,001–$1 million), a gift trust ($1–5 million), and direct equity ($500,001–$1 million). He serves as an uncompensated board member and holds a 2009 agreement guaranteeing his "right to return after government service." The company received a $4,367,200 Paycheck Protection Program loan, forgiven, and three Small Business Administration loans totaling $5.6 million in 2010–12. A member of the Aluminum Caucus, he said in 2018 he would back requiring congressional approval of new tariffs, a position Sludge said likely aligned with companies like his; a Public Citizen lobbyist called his board role "a clear conflict of interest." His committee's jurisdiction includes motor-vehicle safety. A retained family business of this scale, held while chairing that committee, is the signal.

Sources: disclosures-clerk.house.gov · readsludge.com · lex18.com +1 more

50Weight 12% 0255075100
04

Earmarks & Member-Directed Spending

Donor / family linkage patterns

$76.65 million secured for FY2026 across thirteen projects, including $50 million for an Army aviation facility at Fort Knox and $14 million for a county water district; FY2027 requests are pending, and FY2025 House earmarks were removed by the March 2025 full-year stopgap. Recipients are public entities; no donor overlap identified.

30Weight 12% 0255075100
05

Ethics Actions

Ethics committees + sanctions

No Office of Congressional Ethics referral or Ethics Committee matter located. Floor-level.

2Weight 13% 0255075100
06

Legal Actions

DOJ / SEC / IRS / state AG / FEC

None located. Floor-level.

2Weight 13% 0255075100
07

Revolving Door

Pre/post office + staff density

An Army officer and family-business executive before office. His chief of staff left for Todd Strategy Group, representing Alkermes, Alnylam, Amgen, and more than seventy other clients; a deputy chief of staff went in-house at Alkermes; a former intern is at a lobbying firm; and an aide who left in 2011 reached BlackRock after later government posts. A health-committee-to-pharma pipeline at its senior levels.

Sources: quiverquant.com

36Weight 10% 0255075100
08

Travel, Gifts & Disclosure

STOCK Act + gifts + filings

No sponsored travel by the member or gifts reported. His disclosures are handwritten on outdated forms and carry errors he has acknowledged — income entered in the wrong column, a co-signed mortgage with no amount range, fund-type boxes left blank. His latest report was filed on time; his 2020 and 2021 reports used extensions. Low signal on substance; weak on form.

18Weight 10% 0255075100

Why the score is what it is

Brett Guthrie: 46 out of 100

Guthrie's score is driven by donor capture and family enrichment. He was the top recipient of pharmaceutical and health-products money in Congress in the 2024 cycle, at $507,000, and his career total of more than $1.8 million is the most of any sitting House Republican; that cycle he also ranked first in the House in health services and first in Congress in medical devices and drug manufacturing. On taking the Energy and Commerce gavel in 2025 his PAC receipts more than doubled, with about a hundred committees giving for the first time. He cosponsored a bill to delay Medicare drug-price negotiation that drugmakers frequently cited in their lobbying. Separately, he reports owning 25 percent of Trace Die Cast, his family's aluminum auto-parts manufacturer, held largely through family trusts valued at $5–25 million and $1–5 million; he sits on its board and his main trust reports six-figure dividends. The company received a $4.4 million forgiven pandemic loan and earlier small-business loans, and its industry falls within his committee's jurisdiction. His chief of staff left for a lobbying firm whose clients include drugmakers. He holds no publicly traded individual stocks and has no ethics or legal matter on record.

Sources

Part II14 documents linked

Built from publicly available primary and secondary documents, including: House Clerk financial disclosures, read directly; Federal Election Commission committee totals; OpenSecrets industry data as reported by Sludge and by States Newsroom (via the Kentucky Lantern); the bill text of H.R. 7174 (118th Congress); USAspending records of Trace Die Cast's federal loans; lobbying registrations as compiled by Quiver Quantitative; his office's Community Project Funding releases; NACo on the FY2025 stopgap; and reporting by PolitiFact and LEX18.

No reply on file

Rep. Guthrie has a permanent right of reply. The subject of this dossier has not submitted a response. Statements of up to 1,000 words are published verbatim.

Subject or representative: submit reply →